Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan H Esensten

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 17, 2013
microRNA-17-92 regulates IL-10 production by regulatory T cells and control of experimental autoimmune encephalomyelitisDimitri de Kouchkovsky, Jonathan H Esensten, Wendy L Rosenthal, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 24, 2025
Automated manufacturing of cell therapiesAlice Melocchi, Brigitte Schmittlein, Sudeshna Sadhu, et al.
The Journal of Pathology|August 4, 2015
Cdk8 deletion in the Apc(Min) murine tumour model represses EZH2 activity and accelerates tumourigenesisMark L McCleland, Tim M Soukup, Scot D Liu, et al.
The Journal of Experimental Medicine|July 24, 2013
CD28-inducible transcription factor DEC1 is required for efficient autoreactive CD4+ T cell responseMarc Martínez-Llordella, Jonathan H Esensten, Samantha L Bailey-Bucktrout, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 4, 2011
Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetesStephanie A McClymont, Amy L Putnam, Michael R Lee, et al.
American Journal of Clinical Pathology|January 5, 2021
Hospital-Based Donor Recruitment and Predonation Serologic Testing for COVID-19 Convalescent PlasmaJoanna Balcerek, Evelin Trejo, Kendall Levine, et al.
Open Forum Infectious Diseases|August 18, 2021
Characteristics of High-Titer Convalescent Plasma and Antibody Dynamics After Administration in Patients With Severe Coronavirus Disease 2019Emma D Bainbridge, Priscilla Y Hsue, Jonathan H Esensten, et al.
Frontiers in Immunology|December 6, 2021
Polyclonal Regulatory T Cell Manufacturing Under cGMP: A Decade of ExperienceJoanna Balcerek, Brian R Shy, Amy L Putnam, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 27, 2021
Magnitude and Kinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Responses and Their Relationship to Disease SeverityKara L Lynch, Jeffrey D Whitman, Noreen P Lacanienta, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2025
Gene-corrected regulatory T cell therapy for IL2RA deficiencyAlvin S Ha, Nechama Kalter, Michael Rosenberg, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|July 17, 2013
microRNA-17-92 regulates IL-10 production by regulatory T cells and control of experimental autoimmune encephalomyelitisDimitri de Kouchkovsky, Jonathan H Esensten, Wendy L Rosenthal, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 24, 2025
Automated manufacturing of cell therapiesAlice Melocchi, Brigitte Schmittlein, Sudeshna Sadhu, et al.
The Journal of Pathology|August 4, 2015
Cdk8 deletion in the Apc(Min) murine tumour model represses EZH2 activity and accelerates tumourigenesisMark L McCleland, Tim M Soukup, Scot D Liu, et al.
The Journal of Experimental Medicine|July 24, 2013
CD28-inducible transcription factor DEC1 is required for efficient autoreactive CD4+ T cell responseMarc Martínez-Llordella, Jonathan H Esensten, Samantha L Bailey-Bucktrout, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 4, 2011
Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetesStephanie A McClymont, Amy L Putnam, Michael R Lee, et al.
American Journal of Clinical Pathology|January 5, 2021
Hospital-Based Donor Recruitment and Predonation Serologic Testing for COVID-19 Convalescent PlasmaJoanna Balcerek, Evelin Trejo, Kendall Levine, et al.
Open Forum Infectious Diseases|August 18, 2021
Characteristics of High-Titer Convalescent Plasma and Antibody Dynamics After Administration in Patients With Severe Coronavirus Disease 2019Emma D Bainbridge, Priscilla Y Hsue, Jonathan H Esensten, et al.
Frontiers in Immunology|December 6, 2021
Polyclonal Regulatory T Cell Manufacturing Under cGMP: A Decade of ExperienceJoanna Balcerek, Brian R Shy, Amy L Putnam, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 27, 2021
Magnitude and Kinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Responses and Their Relationship to Disease SeverityKara L Lynch, Jeffrey D Whitman, Noreen P Lacanienta, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2025
Gene-corrected regulatory T cell therapy for IL2RA deficiencyAlvin S Ha, Nechama Kalter, Michael Rosenberg, et al.
Pageof 3